Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study
Background: : Oxytocin and Vasopressin systems in the brain sustain adaptation to stressors. Cocaine being a stressor, it may alter brain homeostatic function. This dysregulation may entrench cocaine use disorder. Method: : This is a human laboratory study of the effects of intranasal desmopressin (...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | Drug and Alcohol Dependence Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772724623000288 |
_version_ | 1797801645446266880 |
---|---|
author | Wilfrid Noël Raby Matthew Heller Demetrios Milliaressis C. Jean Choi Cale Basaraba Frances R. Levin Sarah Church Martina Pavlicova Edward V. Nunes |
author_facet | Wilfrid Noël Raby Matthew Heller Demetrios Milliaressis C. Jean Choi Cale Basaraba Frances R. Levin Sarah Church Martina Pavlicova Edward V. Nunes |
author_sort | Wilfrid Noël Raby |
collection | DOAJ |
description | Background: : Oxytocin and Vasopressin systems in the brain sustain adaptation to stressors. Cocaine being a stressor, it may alter brain homeostatic function. This dysregulation may entrench cocaine use disorder. Method: : This is a human laboratory study of the effects of intranasal desmopressin (a Vasopressin 1b receptor agonist) and oxytocin on ACTH secretion in cocaine use disorder patients versus a control group. It consisted of two endocrine challenges performed on consecutive days. On day 1, the effect of intranasal desmopressin (80 IU) on ACTH secretion was measured. On day 2, a pre-treatment with intranasal oxytocin (24 IU) preceded intranasal desmopressin to monitor its effect on desmopressin-induced ACTH secretion. We hypothesized that the effect of intranasal oxytocin in controls would differ from the effect in cocaine use disorder patients. Results: : Forty-three patients were included in this study: 14 controls and 29 cocaine use disorder patients. Significant differences were noted in the direction of change of ACTH secretion between the two groups. In cocaine use disorder patients, overall ACTH secretion was on average 2.7 pg/ml/min higher after intranasal desmopressin than after intranasal oxytocin/desmopressin (t292 = 2.91, p = 0.004). The opposite was observed in controls: overall ACTH secretion averaged 3.3 pg/ml/min less after intranasal desmopressin than after intranasal oxytocin/desmopressin (t292 = -2.35, p = 0.02). Conclusion: : Intranasal oxytocin and desmopressin revealed a pattern of ACTH secretion in cocaine use disorder patients that is distinct from a non-addicted control group. (ClinicalTrial.gov00255357, 10/2014) |
first_indexed | 2024-03-13T04:53:37Z |
format | Article |
id | doaj.art-804d3b4dcb8546618b587daece9f1593 |
institution | Directory Open Access Journal |
issn | 2772-7246 |
language | English |
last_indexed | 2024-03-13T04:53:37Z |
publishDate | 2023-06-01 |
publisher | Elsevier |
record_format | Article |
series | Drug and Alcohol Dependence Reports |
spelling | doaj.art-804d3b4dcb8546618b587daece9f15932023-06-18T05:04:21ZengElsevierDrug and Alcohol Dependence Reports2772-72462023-06-017100158Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory studyWilfrid Noël Raby0Matthew Heller1Demetrios Milliaressis2C. Jean Choi3Cale Basaraba4Frances R. Levin5Sarah Church6Martina Pavlicova7Edward V. Nunes8Division on Substance Abuse, Department of Psychiatry, Montefiore Medical Center, Albert Einstein College of Medicine, 1510 Waters Place, 2nd Floor, Bronx, NY, 10461; Division on Substance Use Disorders, Department of Psychiatry, Columbia University Irving Medical Center and the New York State Psychiatric Institute, New York, NY, USA; Corresponding author.Division on Substance Use Disorders, Department of Psychiatry, Columbia University Irving Medical Center and the New York State Psychiatric Institute, New York, NY, USADivision on Substance Use Disorders, Department of Psychiatry, Columbia University Irving Medical Center and the New York State Psychiatric Institute, New York, NY, USADivision of Mental Health Data Science, New York State Psychiatric Institute, New York, NY, USADivision of Mental Health Data Science, New York State Psychiatric Institute, New York, NY, USADivision on Substance Use Disorders, Department of Psychiatry, Columbia University Irving Medical Center and the New York State Psychiatric Institute, New York, NY, USAWholeview Wellness Centers, 369 Lexington Avenue, Suite 14A, New York City, NY, 10017, USADepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USADivision on Substance Use Disorders, Department of Psychiatry, Columbia University Irving Medical Center and the New York State Psychiatric Institute, New York, NY, USABackground: : Oxytocin and Vasopressin systems in the brain sustain adaptation to stressors. Cocaine being a stressor, it may alter brain homeostatic function. This dysregulation may entrench cocaine use disorder. Method: : This is a human laboratory study of the effects of intranasal desmopressin (a Vasopressin 1b receptor agonist) and oxytocin on ACTH secretion in cocaine use disorder patients versus a control group. It consisted of two endocrine challenges performed on consecutive days. On day 1, the effect of intranasal desmopressin (80 IU) on ACTH secretion was measured. On day 2, a pre-treatment with intranasal oxytocin (24 IU) preceded intranasal desmopressin to monitor its effect on desmopressin-induced ACTH secretion. We hypothesized that the effect of intranasal oxytocin in controls would differ from the effect in cocaine use disorder patients. Results: : Forty-three patients were included in this study: 14 controls and 29 cocaine use disorder patients. Significant differences were noted in the direction of change of ACTH secretion between the two groups. In cocaine use disorder patients, overall ACTH secretion was on average 2.7 pg/ml/min higher after intranasal desmopressin than after intranasal oxytocin/desmopressin (t292 = 2.91, p = 0.004). The opposite was observed in controls: overall ACTH secretion averaged 3.3 pg/ml/min less after intranasal desmopressin than after intranasal oxytocin/desmopressin (t292 = -2.35, p = 0.02). Conclusion: : Intranasal oxytocin and desmopressin revealed a pattern of ACTH secretion in cocaine use disorder patients that is distinct from a non-addicted control group. (ClinicalTrial.gov00255357, 10/2014)http://www.sciencedirect.com/science/article/pii/S2772724623000288IntranasalOxytocinCocaineStressACTH |
spellingShingle | Wilfrid Noël Raby Matthew Heller Demetrios Milliaressis C. Jean Choi Cale Basaraba Frances R. Levin Sarah Church Martina Pavlicova Edward V. Nunes Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study Drug and Alcohol Dependence Reports Intranasal Oxytocin Cocaine Stress ACTH |
title | Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study |
title_full | Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study |
title_fullStr | Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study |
title_full_unstemmed | Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study |
title_short | Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study |
title_sort | cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin report on a laboratory study |
topic | Intranasal Oxytocin Cocaine Stress ACTH |
url | http://www.sciencedirect.com/science/article/pii/S2772724623000288 |
work_keys_str_mv | AT wilfridnoelraby cocaineusedisorderpatientsdevelopdistinctpatternsofregulationofacthsecretionbyavasopressinagonistandoxytocinreportonalaboratorystudy AT matthewheller cocaineusedisorderpatientsdevelopdistinctpatternsofregulationofacthsecretionbyavasopressinagonistandoxytocinreportonalaboratorystudy AT demetriosmilliaressis cocaineusedisorderpatientsdevelopdistinctpatternsofregulationofacthsecretionbyavasopressinagonistandoxytocinreportonalaboratorystudy AT cjeanchoi cocaineusedisorderpatientsdevelopdistinctpatternsofregulationofacthsecretionbyavasopressinagonistandoxytocinreportonalaboratorystudy AT calebasaraba cocaineusedisorderpatientsdevelopdistinctpatternsofregulationofacthsecretionbyavasopressinagonistandoxytocinreportonalaboratorystudy AT francesrlevin cocaineusedisorderpatientsdevelopdistinctpatternsofregulationofacthsecretionbyavasopressinagonistandoxytocinreportonalaboratorystudy AT sarahchurch cocaineusedisorderpatientsdevelopdistinctpatternsofregulationofacthsecretionbyavasopressinagonistandoxytocinreportonalaboratorystudy AT martinapavlicova cocaineusedisorderpatientsdevelopdistinctpatternsofregulationofacthsecretionbyavasopressinagonistandoxytocinreportonalaboratorystudy AT edwardvnunes cocaineusedisorderpatientsdevelopdistinctpatternsofregulationofacthsecretionbyavasopressinagonistandoxytocinreportonalaboratorystudy |